AUBREY STRANGE: Open Payments
NPI 1952830150 · SAREPTA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 15 payments from 8 companies in 2025. Trend: 2023 $323 · 2024 $299 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $88 |
| Tris Pharma Inc | 2 | $45 |
| Lilly USA, LLC | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: VRAYLAR, Dyanavel XR, KEVEYIS, ZEPBOUND, MOUNJARO, QULIPTA, FARXIGA, TRELEGY ELLIPTA.
Industry payments across LA — which companies pay providers there.
